Kawasaki disease: A review

Radiology

Volumn 208, Issue 1, 1998, Pages 25-33

  Chung, Charles J ^a   Stein, Leonard ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN; SUPERANTIGEN;

CARDIOVASCULAR DISEASE; CHILD; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY OBSTRUCTION; FEVER; GASTROINTESTINAL DISEASE; HUMAN; IMAGING; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LUNG COMPLICATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCULOSKELETAL DISEASE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; REVIEW; STEROID THERAPY;

EID: 0031878358     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.208.1.9646789     Document Type: Review

References (101)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observation of 50 cases. Jpn J Allerg 1967; 16:178-222.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics 1974; 54:271-276.
3. Melish CE, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976, 130:599-607.
4. Shulman ST, Bass JL, Bierman F, et al. Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the third international Kawasaki disease symposium, Tokyo, Japan, December, 1988. Pediatr Infect Dis J 1989; 8:663-665.
5. Kawasaki T. Kawasaki disease. Acta Paediatr 1995, 84:713-715.
6. Shulman ST, De Inocencio J, Hirsh R. Kawasaki disease. Pediatr Clin North Am 1995; 42:1205-1222.
7. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 1992; 340:1127-1129.
8. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10 to 21 year follow-up study of 594 patients. Circulation 1996; 94:1379-1385.
9. Fukushige J, Takahashi N, Ueda K, Hijii T, Ohshima A. Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 1996; 17:71-76.
10. Takahashi N, Fukushige J, Htii T, Igarashi H, Ooshima A, Ueda K. Occlusion of the right coronary artery as sequelae of Kawasaki disease: the clinical features of nine cases. Cardiology 1995; 86:207-210.
11. Vogel M, Smallhorn JF, Freedon RM. Serial analysis of regional left ventricular wall motion by two-dimensional echocardiography in patients with coronary artery enlargement after Kawasaki disease. J Am Coll Cardiol 1992; 20:915-919.
12. Leung DYM. Kawasaki disease. Curr Opin Rheumatol 1993; 7:455-458.
13. Masuda H, Shozawa T, Naoe S, Tanaka N. The intercostal artery in Kawasaki disease. Arch Pathol Lab Med 1986; 110:1136-1142.
14. Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease: on the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30:681-694.
15. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61:100-107.
16. Masuda H, Naoe S, Tanaka N. A pathological study of coronary artery in Kawasaki disease (MCLS) with special reference to morphogenesis of aneurysm. J Jpn Coll Angiol 1981; 21:899-912.
17. Amano S, Hazama F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 1980; 30:365-373.
18. Rauch AM. Kawasaki syndrome: critical review of US epidemiology. Prog Clin Biol Res 1987; 250:33-44.
19. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Dato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med 1995; 149:779-783.
20. Smith PK, Goldwater PN. Kawasaki disease in Adelaide: a review. J Paediatr Child Health 1993; 29:126-131.
21. Salo E. Kawasaki disease in Finland in 1982-1992. Scand J Infect Dis 1993; 25:497-502.
22. Windsor AMB, Schell WL, Davis JP. Kawasaki syndrome in Wisconsin. Wis Med J 1991; 90:227-231.
23. Casey F, Craig B, Shanks D, Jackson P, Mulholland HC. Kawasaki disease: the Northern Ireland experience. Ir J Med Sci 1993; 162:397-400.
24. St John MA, Ishmael RG. Outcome of Kawasaki disease in Barbados. West Indian Med J 1992; 41:68-71.
25. Meade RH, Brandt L. Manifestations of Kawasaki dsease in New England outbreak of 1980. J Pediatr 1982; 100:558-562.
26. Tizard EJ, Suzuki A, Levin M, Dillon MJ. Clinical aspects of 100 patients with Kawasaki disease. Arch Dis Child 1991; 66:185-188.
27. Schiller B, Fasth A, Bjorkhem G, Elinder G. Kawasaki disease in Sweden: incidence and clinical fetures. Acta Paediatr 1995; 84:769-774.
28. Tsuchida S, Yamanaka T, Tsuchida R, Nakamura Y, Yashiro M, Yanagawa H. Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr 1996; 85:995-997.
29. Paira SO, Roverano S. Kawasaki syndrome in a young adult. J Rheumatol 1992; 19:488-490.
30. Jackson JL, Kunkel MR, Libow L, Gates RH. Adult Kawasaki disease. Arch Intern Med 1994; 154:1398-1404.
31. Nakamura T, Yanagawa H, Kawasaki T. Mortality among children with Kawasaki disease in Japan. N Engl J Med 1992; 326:1246-1249.
32. Nakamura Y, Yanagawa H, Kato H, Kawasaki T. Mortality rates for patients with a history of Kawasaki disease in Japan. J Pediatr 1996; 128:75-81.
33. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991; 119: 279-282.
34. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342:1385-1388.
35. Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease: report from the Committee on Rheumatic Fever, Endocartitis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994; 89:916-922.
36. Patriarca PA, Rogers M, Morens D, et al. Kawasaki syndrome: association with the application of rug shampoo, Lancet 1982; ii:578-580.
37. Rauch AM. Kawasaki syndrome: review of new epidemiologic and laboratory developments. Pediatr Infect Dis J 1987; 6:1016-1021.
38. Rauch AM, Kaplan SL, Nihill MR, Pappas PG, Hurwitz ES, Schonberger LB. Kawasaki syndrome clusters in Harris County, Texas and Eastern North Carolina: a high endemic rate and a new environmental risk factor. Am J Dis Child 1988; 142:441-444.
39. Rauch AM, Glode MP, Wiggins JW, et al. Outbreak of Kawasaki syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics 1991; 87:663-669.
40. Fujita Y, Nakamura T, Sakata K, et al. Kawaski disease in families. Pediatrics 1989; 84:666-669.
41. Nigro G, Pisano P, Krzysztofiak A. Recurrent Kawasaki disease associated with co-infection with parvovirus B19 and HIV-1. AIDS 1993; 7:288-290.
42. Leung DYM. Immunologic aspects of Kawasaki disease: implications for pathogenesis and therapy. Clin Cardiol 1991; 14(suppl 2):11-15.
43. ß8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89: 4066-4070.
44. Lang BA, Silverman ED, Laxer RM, Rose V, Nelson DL, Rubin LA. Serum-soluble interleukin-2 receptor levels in Kawasaki disease. J Pediatr 1990; 116:592-596.
45. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991; 86:134-139.
46. Meissner HC, Leung DYM. Kawasaki syndrome. Curr Opin Rheumatol 1995; 7:455-458.
47. Drake CG, Kotzin BL. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol 1992; 12:149-162.
48. Leung DYM. Superantigens related to Kawasaki syndrome. Springer Semin Immunopathol 1996; 17:385-396.
49. Resnick SD. Toxic shock syndrome: recent developments in pathogenesis. J Pediatr 1990; 116:321-328. J
50. Leung DYM. Kawasaki syndrome: immuno-modulatory benefit and potential toxin neutralization by intravenous immune globulin. Clin Exp Immunol 1996; 104(suppl 1):49-54.
51. + T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996; 39:264-266.
52. Yamashiro Y, Nagata S, Ohtsuka Y, Ogushi S, Shimizu T. Microbiologic studies on the small intestine in Kawasaki disease. Pediatr Res 1996; 39:622-624.
53. Burns JC, Mason WH, Glode MPS, et al. Clinical and epidemiologic characeristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991; 118:680-686.
54. Hester TO, Harris JP, Kenny JF, Albernaz MS. Retropharyngeal cellulitis: a manifestation of Kawasaki disease in children. Otolaryngol Head Neck Surg 1993; 109:1030-1033.
55. Pontell J, Rosenfeld RM, Kohn B. Kawasaki disease mimicking retropharyngeal abscess. Otolaryngol Head Neck Surg 1994; 110:428-430.
56. Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994; 83:1057-1060.
57. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants: do we need criteria? West J Med 1995; 162:322-327.
58. Boven K, DeGraeff-Meeder ER, Spliet W, Kuis W. Atypical kawasaki disease: an often missed diagnosis. Eur J Pediatr 1992; 151:577-580.
59. Lacroix J, Lapointe N, Weber M, et al. Prospective study of 64 cases of Kawasaki's disease. Arch Fran Pediatr 1985; 42:771-776.
60. Terasawa K, Ichinose E, Matsuishi T, Kato H. Neurological complications in Kawasaki disease. Brain Dev 1993; 5:371-374.
61. Gallagher PG. Facial nerve paralysis and Kawasaki disease. Rev Infect Dis 1990; 12:403-405.
62. Kryzer T, Derkay DS. Kawasaki disease: five-year experience at Children's National Medical Center. Int J Pediatr Otorhinolaryngol 1992; 23:211-220.
63. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995; 126:524-529.
64. Ohga S, Ooshima A, Fukushige J, Ueda K. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995; 154:539-541.
65. Waring NP, Ortenberg J, Galen WK, Robinson C, Baker A. Priapism in Kawasaki disease. JAMA 1989; 261:1730-1731.
66. Sacco M, Meleleo D, Castriota Scanderbeg A. Hydrocele in Kawasaki disease. Pediatr Med Chir 1995; 17:279-280.
67. Lee B, Yap H, Yip W, Giam Y, Tay J. Nephrotic syndrome in Kawasaki disease. Aust Pediatr J 1989; 25:241-242.
68. Nardi P, Haller J, Friedman A, Slovis T, Schaffer R. Renal manifestations of Kawasaki's disease. Pediatr Radiol 1985; 15:116-118.
69. Huang Y, Lin T, Su W. Unusual manifestations in children with Kawasaki disease. J Formos Med Assoc 1997; 96:451-456.
70. Dunn MM, Das Narla L, Spiegle JB, Spottswood SE, Hingsbergen EA. Understanding and imaging pediatric patients with Kawasaki syndrome. Adv Administrators Radiol Radiat Oncol 1996; May:21-24.
71. Falcini F, Trpani S, Pampaloni A, Ienuso R, Pollini I, Bartolozzi G. Hydrops of gallbladder requiring cholecystectomy in Kawasaki syndrome. Clin Exp Rheumatol 1990; 11:99-100.
72. Mercer S, Carpenter B. Surgical complications of Kawasaki disease. J Pediatr Surg 1981; 16:444-448.
73. Wheeler R, Najmaldin A, Soubra M, Griffiths D, Burge D, Atwell J. Surgical presentation of Kawasaki disease (mucocutaneous lymph node syndrome). Br J Surg 1990; 77:1273-1274.
74. Waldron RJ. Kawasaki disease and anaesthesia. Anaesth Intensive Care 1993; 21:213-217.
75. Huong D, Gatfosse M, Papo T, Barjonet G, Lacombe P, Godeau P. Symptomatic splenic infarction complicating adult Kawasaki disease. Br J Rheumatol 1995; 34:579-580.
76. Lanting W, Muinos W, Kamani N. Pancreatitis heralding Kawasaki disease. J Pediatr 1992; 21:743-744.
77. Murphy DJ, Morrow WR, Harberg FJ, Hawkins EP. Small bowel obstruction as a complication of Kawasaki disease. Clin Pediatr 1987; 26:193-196.
78. Fan S, Lau W, Wong K. Ischemic colitis in Kawasaki disease. J Pediatr Surg 1986; 21:964-965.
79. Franken E, Kleiman M, Norins A, Smith J, Smith W. Intestinal pseudo-obstuction in mucocutaneous lymph-node syndrome. Radiology 1979; 130:649-651.
80. Chung CJ, Rayder S, Meyers W, Long J. Kawasaki disease presenting as focal colitis. Pediatr Radiol 1996; 26:455-457.
81. Gear J, Meyers K, Steele M. Kawasaki disease manifesting with acute cholangitis. S Afr Med J 1991; 81:31-33.
82. Bader-Meunier B, Hadchouel M, Fabre M, Arnoud MD, Dommergues JP. Intrahepatic bile duct damage in children with Kawasaki disease. J Pediatr 1992; 120:750-752.
83. Umezawa T, Saji T, Matsuo N, Odagiri K. Chest x-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol 1989; 20:48-51.
84. Herrero J, Ornia N, Serrano O, et al. Kawasaki's syndrome in the adult and bilateral sacroiliitis. Ann Med Interne 1995; 12:549-545.
85. Koutras A. Myositis with Kawasaki's disease. Am J Dis Child 1982; 136:78-79.
86. Yanagitani Y, Fujita M. Avascular necrosis of the femoral head associated with mucocutaneous lymph node syndrome. J Pediatr Orthop 1986; 6:107-109.
87. von Planta M, Fasnacht M, Holm C, Fanconi S, Seger R. Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: therapeutic implications. Eur J Pediatr 1995; 154:830-834.
88. Tomita S, Chung K, Mas M, Gidding S, Shulman ST. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis 1992; 14:121-126.
89. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28:253-257.
90. Bisset GS, Strife JL, McCloskey J. MR imaging of coronary artery aneurysms in a child with Kawasaki disease. AJR 1989; 152:805-807.
91. Hijazi ZM, Udelson JE, Snapper H, et al. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1994; 24:1633-1638.
92. Kao CH, Hsieh KS, Chen YC, Wang YL, Wang SJ, Yen SH. Labeled WBC cardiac imaging and two-dimensional echocardiography to evaluate high-dose gamma globulin treatment in Kawasaki disease. Clin Nucl Med 1995; 20:813-816.
93. Mishima A, Asano M, Saito T, et al. Mitral regurgitation caused by ruptured chordae tendineae in Kawasaki disease. J Thorac Cardiovasc Surg 1996; 111:895-896.
94. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324:1633-1639.
95. Hsu CH, Chen MR, Hwang FY, Kao HA, Hung HY, Hsu CS. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome. Pediatr Infect Dis J 1993; 12:509-511.
96. Durongpistkul D, Gururaj V, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995; 96: 1057-1061.
97. Kitamura S, Yoichi K, Seki T, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. J Thorac Cardiovasc Surg 1994; 107:663-674.
98. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993; 123:657-659.
99. Wolf HM, Eibl MM. Immunomodulatory effect of immunoglobulins. Clin Exp Rheumatol 1996; 14(suppl 15):17-25.
100. Kato H, Koike S, Yokomaya T. Kawasaki disease: effect of treatment on coronary involvement. Pediatrics 1976; 63:175-179.
101. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128:146-149.